Lundbeck
HLUN-B.CO
#2346
Rank
โ‚น548.29 B
Marketcap
โ‚น566.85
Share price
0.98%
Change (1 day)
27.21%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Revenue for Lundbeck (HLUN-B.CO)

Revenue in 2024 (TTM): โ‚น248.98 B

According to Lundbeck 's latest financial reports the company's current revenue (TTM) is โ‚น250.76 B. In 2023 the company made a revenue of โ‚น241.25 B an increase over the revenue in the year 2022 that were of โ‚น213.67 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lundbeck from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น248.98 B3.2%
2023 โ‚น241.25 B12.91%
2022 โ‚น213.67 B12.42%
2021 โ‚น190.07 B-5.1%
2020 โ‚น200.29 B8.22%
2019 โ‚น185.07 B-5.7%
2018 โ‚น196.26 B15.47%
2017 โ‚น169.96 B7.88%
2016 โ‚น157.55 B9.63%
2015 โ‚น143.72 B-3.99%
2014 โ‚น149.69 B-10.66%
2013 โ‚น167.56 B18.24%
2012 โ‚น141.71 B-9.69%
2011 โ‚น156.92 B34.16%
2010 โ‚น116.96 B-3.4%
2009 โ‚น121.07 B